Last update:

Alzheimer's disease & dementia news

Medical research

Dietary compound increases longevity and protects against Alzheimer's disease in experimental models

Researchers from the Color and Food Quality group at the Faculty of Pharmacy (University of Seville), in collaboration with Dr. Marina Ezcurra's group at the University of Kent (U.K.), have shown that the carotenoid phytoene ...

Alzheimer's disease & dementia

Questions over safety and effectiveness of new Alzheimer's drug

The safety and effectiveness of donanemab—an Alzheimer's drug recently approved by the US Food & Drug Administration (FDA)—is called into question in an investigation published by The BMJ.

Genetics

Master copper regulator discovery may offer Alzheimer's clues

New therapeutic opportunities often emerge from research on simple organisms. For instance, the 2020 Nobel Prize in Chemistry awarded to Emmanuelle Charpentier, Ph.D., and Jennifer Doudna, Ph.D., for their CRISPR-based DNA ...

Alzheimer's disease & dementia

Boosting brain protein levels may slow decline from Alzheimer's

A study published in the journal Brain shows that increases in protein levels with new Alzheimer's drugs can explain the slowing of cognitive impairment at least as well as the reduction in amyloid plaques.

Alzheimer's disease & dementia

Scientists tie obesity to Alzheimer's-related genes

In a new study, researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) link obesity with 21 Alzheimer's disease-related genes, providing a potential mechanistic explanation for ...

Alzheimer's disease & dementia

Neuropsychologist argues for implementing value-based dementia care

The New England Journal of Medicine (NEJM) Catalyst recently published an article by Ochsner Health neuropsychologist R. John Sawyer, Ph.D. along with Ashley LaRoche, CCRC, Sakshi Sharma, MS and Carolina Pereira-Osorio, MS. ...

Neuroscience

How frontotemporal dementia changes the brain

Around 55 million people worldwide suffer from dementia such as Alzheimer's disease. Recently, the actor Bruce Willis was diagnosed with frontotemporal dementia, or FTD, a rare type of dementia that typically affects people ...

Health

10 ways to reduce your risk of dementia

Dementia affects millions of Americans—including nearly one in 10 adults over age 65. While the causes of different dementias vary, a 2020 report from a Lancet commission identified several modifiable risk factors that ...

Neuroscience

What is frontotemporal degeneration?

Frontotemporal degeneration (FTD) is a group of neurologic disorders associated with changes in personality, behavior, language or movement. Some FTD forms are inherited, and some are not. Typically, people develop FTD symptoms ...

Alzheimer's disease & dementia

Big data initiative discovers new causal pathways in Alzheimer's

A new study, published on Feb. 15 in Alzheimer's & Dementia, analyzed biological samples from hundreds of individuals from a European study. Researchers looked at the biological information at various levels—genes, proteins, ...

Medications

Drug linked to lower risk of dementia in people with diabetes

People with diabetes are twice as likely to develop dementia as those without the disease. In a new study, people with newly diagnosed type 2 diabetes who took the diabetes drug pioglitazone were less likely to later develop ...

Neuroscience

Study suggests fructose could drive Alzheimer's disease

An ancient human foraging instinct, fueled by fructose production in the brain, may hold clues to the development and possible treatment of Alzheimer's disease (AD), according to researchers at the University of Colorado ...

Medications

New hope for first treatment for strokes linked to dementia

Two cheap and common drugs could be re-purposed as the first specific treatment for people who experience a type of stroke linked to nearly half of all dementias, according to the results of new research.